DK645489D0 - Antiglaukompraeparater indeholdende kombinationer af sympatomimetiske midler og beta-1 selektive beta-blokkere - Google Patents

Antiglaukompraeparater indeholdende kombinationer af sympatomimetiske midler og beta-1 selektive beta-blokkere

Info

Publication number
DK645489D0
DK645489D0 DK645489A DK645489A DK645489D0 DK 645489 D0 DK645489 D0 DK 645489D0 DK 645489 A DK645489 A DK 645489A DK 645489 A DK645489 A DK 645489A DK 645489 D0 DK645489 D0 DK 645489D0
Authority
DK
Denmark
Prior art keywords
beta
antiglauc
sympatomimetic
agents
selective
Prior art date
Application number
DK645489A
Other languages
Danish (da)
English (en)
Other versions
DK645489A (da
Inventor
Louis De Santis
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22684861&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK645489(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of DK645489D0 publication Critical patent/DK645489D0/da
Publication of DK645489A publication Critical patent/DK645489A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
DK645489A 1988-04-26 1989-12-19 Antiglaukompraeparater indeholdende kombinationer af sympatomimetiske midler og beta-1 selektive beta-blokkere DK645489A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18641588A 1988-04-26 1988-04-26
PCT/US1989/001748 WO1989010120A1 (fr) 1988-04-26 1989-04-26 Compositions antiglaucome contenant des combinaisons d'agents sympatomimetiques et de beta-bloquants a selection de beta-1

Publications (2)

Publication Number Publication Date
DK645489D0 true DK645489D0 (da) 1989-12-19
DK645489A DK645489A (da) 1989-12-19

Family

ID=22684861

Family Applications (1)

Application Number Title Priority Date Filing Date
DK645489A DK645489A (da) 1988-04-26 1989-12-19 Antiglaukompraeparater indeholdende kombinationer af sympatomimetiske midler og beta-1 selektive beta-blokkere

Country Status (9)

Country Link
EP (1) EP0366765B1 (fr)
JP (1) JPH02504150A (fr)
KR (1) KR0124465B1 (fr)
AT (1) ATE114461T1 (fr)
AU (1) AU617479B2 (fr)
CA (1) CA1338519C (fr)
DE (1) DE68919649T2 (fr)
DK (1) DK645489A (fr)
WO (1) WO1989010120A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201079C3 (de) * 1992-01-17 1997-09-11 Gramer Eugen Kombinationspräparate zur Augeninnendrucksenkung
EP0582321A1 (fr) * 1992-01-17 1994-02-09 Gramer, Eugen, Prof.Dr.med.Dr.jur. Combinaison de dipivalylépinéphrine avec un agent bêta-bloquant pour diminuer la pression intraoculaire
US6015837A (en) * 1996-08-29 2000-01-18 New York Medical College Method for treating scoliosis with β2-adrenoceptor agonists
WO2006015830A1 (fr) * 2004-08-09 2006-02-16 Universite Catholique De Louvain Utilisation d’agonistes et d’antagonistes de bêta-adrénocepteurs pour traiter les maladies artérielles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852468A (en) * 1967-02-27 1974-12-03 Ici Ltd Alkanolamine derivatives as {62 -adrenergic blocking agents

Also Published As

Publication number Publication date
DE68919649T2 (de) 1995-04-06
EP0366765A1 (fr) 1990-05-09
DE68919649D1 (de) 1995-01-12
JPH02504150A (ja) 1990-11-29
AU617479B2 (en) 1991-11-28
CA1338519C (fr) 1996-08-13
KR900700090A (ko) 1990-08-11
EP0366765B1 (fr) 1994-11-30
DK645489A (da) 1989-12-19
ATE114461T1 (de) 1994-12-15
KR0124465B1 (ko) 1997-11-25
WO1989010120A1 (fr) 1989-11-02
AU3555989A (en) 1989-11-24
EP0366765A4 (en) 1990-12-05

Similar Documents

Publication Publication Date Title
SE8403090L (sv) Gel for anvendning som glaskroppssubstitut
EP0794772A4 (fr) Procede accroissant l'evacuation de l'humeur aqueuse dans le traitement du glaucome
ES2042625T5 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
ATE297173T1 (de) System für die augenchirurgie
EP0242580A3 (en) Use of a, b and c prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
IE811654L (en) Ophthalmic composition
ES8605476A1 (es) Un procedimiento para preparar un derivado de acido benzoico.
AU3693789A (en) New ophthalmic preparation for treating glaucoma
PT87620A (pt) Process for preparing thiophene sulfonamide antiglaucoma agents
DK645489A (da) Antiglaukompraeparater indeholdende kombinationer af sympatomimetiske midler og beta-1 selektive beta-blokkere
ES2080330T5 (es) Procedimiento para reducir el contenido residual en agente de alquilacion libre en soluciones acuosas de tensioactivos cationicos.
ES8107021A1 (es) Un procedimiento para preparar una solucion oftalmica que contiene una sal de 2-acetil-7-(2-hidroxi-3-isopropilamino- propoxi) benzofurano.
BE893637A (fr) 1-(p-2-isopropoxyethoxymethyl-phenoxy)-3-isopropyl-amino-propan-2-ol en vue de reduire la pression intra-oculaire et agent ophtalmique contenant ce comose
SE8400445D0 (sv) Novel pharmaceutical active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives, their production and use
ES2118941T3 (es) Composiciones antiglaucoma topicas que comprenden inhibidores de anhidrasa carbonica y bloqueantes beta.
FI894029A0 (fi) Medel foer fixering av frisyren och foer haorvaord.
EP0114048A3 (en) Use of d,l and d-carazolole as an antiglaucoma agent, and pharmaceutical compositions containing them
IT1098997B (it) Procedimento per l'applicazione di occhi di supporto su parti di costruzione da supportare in modo oscillabile
ES2088489T3 (es) Uso de prostaglandina f3alfa como agente ocular hipotensivo.
EP0406993A3 (en) Substituted benzoxazolinone and benzoxazinone derivatives, process for their preparation and their use as agent with herbicide activity
AU5992786A (en) Increasing aqueous humor outflow
EP0227416A3 (fr) Agonistes de la dopamine pour traiter une pression intraoculaire élevée
IT8821747A0 (it) Espianto per il corroboramento chirurgico della sclera deformata del bulbo oculare.
MX9202807A (es) Conposiciones y metodos para tratamiento de glaucoma por la administracion topica de t-butilamino-3(4-morfolin-1,2,5-tiadiazol-3-iloxi-2-propanol hidrogeno maleato.
IT8841683A0 (it) Dispositivo oftalmologico in particolare per l'asportazione di umore vitreo, cateratte molli e membrane preretinali.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment